Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
FOLR1 overexpression
i
Other names:
FOLR1, Folate Receptor Alpha, Ovarian Tumor-Associated Antigen MOv18, Adult Folate-Binding Protein, Folate Receptor 1 (Adult), Folate Receptor, Adult, Folate Receptor 1, KB Cells FBP, FR-Alpha, FOLR, FBP, Folate Binding Protein, FRalpha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
2348
Related biomarkers:
Expression
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
FOLR1 overexpression
Ovarian Cancer
FOLR1 overexpression
Ovarian Cancer
mirvetuximab soravtansine-gynx
Sensitive: B - Late Trials
mirvetuximab soravtansine-gynx
Sensitive
:
B
mirvetuximab soravtansine-gynx
Sensitive: B - Late Trials
mirvetuximab soravtansine-gynx
Sensitive
:
B
FOLR1 overexpression
Ovarian Cancer
FOLR1 overexpression
Ovarian Cancer
PARP inhibitor
Resistant: C3 – Early Trials
PARP inhibitor
Resistant
:
C3
PARP inhibitor
Resistant: C3 – Early Trials
PARP inhibitor
Resistant
:
C3
FOLR1 overexpression
Gastric Cancer
FOLR1 overexpression
Gastric Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
C3
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
C3
FOLR1 overexpression
Ovarian Cancer
FOLR1 overexpression
Ovarian Cancer
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
C3
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive: C3 – Early Trials
bevacizumab + mirvetuximab soravtansine-gynx
Sensitive
:
C3
FOLR1 overexpression
Ovarian Cancer
FOLR1 overexpression
Ovarian Cancer
CT900
Sensitive: C3 – Early Trials
CT900
Sensitive
:
C3
CT900
Sensitive: C3 – Early Trials
CT900
Sensitive
:
C3
FOLR1 overexpression
Ovarian Cancer
FOLR1 overexpression
Ovarian Cancer
IMGN-151
Sensitive: D – Preclinical
IMGN-151
Sensitive
:
D
IMGN-151
Sensitive: D – Preclinical
IMGN-151
Sensitive
:
D
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login